Document Detail

Comparison of effects of aprikalim and of hypoxic and ischaemic preconditioning on extracellular potassium accumulation, metabolism, and functional recovery of the globally ischaemic rat heart.
MedLine Citation:
PMID:  7923293     Owner:  NLM     Status:  MEDLINE    
OBJECTIVE: The aim was to compare the effects of a potassium channel opener, aprikalim, and of hypoxic and ischaemic preconditioning on extracellular K+ concentration change, metabolism, and ventricular function in isolated globally ischaemic rat hearts. METHODS: Isovolumetric rat hearts (37 degrees C) were treated with 1 microM (apri 1) or 30 microM (apri 30) aprikalim, or preconditioned with either 10 min of hypoxia (N2PC) or 5 min of ischaemia followed by 5 min of perfusion (IPC5) or 10 min of ischaemia followed by 3 min of perfusion (IPC10). Control hearts received neither treatment nor preconditioning. All hearts received 30 min of sustained ischaemia followed by 25 min of reperfusion. Extracellular K+ concentration was measured with a potassium sensitive electrode inserted into the extracellular space of the left ventricular wall. RESULTS: Recovery of left ventricular developed pressure after 25 min of reperfusion was only 19.20(SEM 5.09)% of the preischaemic level in the control group. No recovery was obtained for the apri 1 group. In contrast, a very good recovery was obtained for the apri 30 group [96.69(10.92)%], the N2PC group [104.92(17.40)%], and the IPC10 group [84.96(9.86)%]. The IPC5 group, however, did not have improved recovery of left ventricular pressure [14.15(5.61)%]; this is likely to be related to differences in the stimulation of anaerobic glycolysis. The protection was also markedly attenuated by pretreatment with 50 microM glibenclamide in the apri 30, N2PC, and IPC10 groups [22.76(9.00), 66.06(6.09), and 46.18(7.06)%, respectively]. Hearts treated with aprikalim before inducing ischaemia showed a concentration dependent increase in [K+]e. Hypoxic (N2PC) and ischaemic preconditioning (IPC5 and IPC10) were also associated with an increase in [K+]e over the 5-10 min period preceding the 30 min of sustained ischaemia. During sustained ischaemia all groups showed a nearly triphasic pattern of extracellular K+ changes with an early rising phase, with the exception of the N2PC group for which the early [K+]e rise was barely detectable. CONCLUSIONS: An increase in [K+]e before sustained ischaemia is one of the mechanisms involved in the conditions affording protection. Although important, this is not sufficient, and further protection may be accomplished by decreased stimulation of anaerobic glycolysis during the sustained ischaemia.
A C Guo; J Diacono; D Feuvray
Related Documents :
8037563 - Forty-hour preservation of the rabbit heart: optimal osmolarity, [mg2+], and ph of a mo...
12163283 - Failure of ibuprofen to prevent progressive dermal ischemia after burning in guinea pigs.
10709063 - Thrombus within an aortic aneurysm does not reduce pressure on the aneurysmal wall.
Publication Detail:
Type:  Comparative Study; Journal Article; Research Support, Non-U.S. Gov't    
Journal Detail:
Title:  Cardiovascular research     Volume:  28     ISSN:  0008-6363     ISO Abbreviation:  Cardiovasc. Res.     Publication Date:  1994 Jun 
Date Detail:
Created Date:  1994-10-24     Completed Date:  1994-10-24     Revised Date:  2006-11-15    
Medline Journal Info:
Nlm Unique ID:  0077427     Medline TA:  Cardiovasc Res     Country:  ENGLAND    
Other Details:
Languages:  eng     Pagination:  864-71     Citation Subset:  IM    
Laboratoire de Physiologie Cellulaire, URA CNRS 1121, Université Paris XI, Orsay, France.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Anoxia / metabolism*,  physiopathology
Antihypertensive Agents / pharmacology*
Basal Metabolism / drug effects
Extracellular Space / metabolism*
Heart / physiopathology
Lactates / metabolism
Lactic Acid
Myocardial Ischemia / metabolism*,  physiopathology
Myocardial Reperfusion
Picolines / pharmacology*
Potassium / metabolism*
Pyrans / pharmacology*
Rats, Wistar
Reg. No./Substance:
0/Antihypertensive Agents; 0/Lactates; 0/Picolines; 0/Pyrans; 50-21-5/Lactic Acid; 7440-09-7/Potassium; 89544-10-5/aprikalim

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine

Previous Document:  Effect of bimakalim (EMD 52692), an opener of ATP sensitive potassium channels, on infarct size, cor...
Next Document:  ATP gated potassium channels in acute myocardial hibernation and reperfusion.